NCT02056119

Brief Summary

Aerosol delivery during mechanical ventilation has long been a long debated topic. As evidence-based knowledge about the delivery of aerosol to the lungs of mechanically ventilated patients increases, one piece of the puzzle has remained unexplored; measurement of clinically relevant outcomes. The primary aim of this research is to compare clinical outcomes (ventilator-associated events (VAEs), length of stay (LOS) in intensive care unit (ICU), and total days on mechanical ventilation) when using a traditional jet nebulizer versus a newer generation vibrating mesh nebulizer during mechanical ventilation. The secondary aim of this research is to identify source of bacteria by obtaining cultures of each nebulizer and ventilator circuit and plating them for colony growth and identification.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 15, 2014

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 5, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
8.5 years until next milestone

Results Posted

Study results publicly available

March 21, 2023

Completed
Last Updated

March 21, 2023

Status Verified

March 1, 2023

Enrollment Period

1.1 years

First QC Date

January 15, 2014

Results QC Date

January 4, 2023

Last Update Submit

March 17, 2023

Conditions

Keywords

Ventilators, mechanicalAerosol Drug TherapyNebulizersEquipment Contaminationvibrating mesh nebulizerjet nebulizermechanical ventilationventilator associated eventventilator associated tracheobronchitis

Outcome Measures

Primary Outcomes (1)

  • Venilator Associated Events (VAE)

    Ventilator associated conditions (VAC) and infection related ventilator associated conditions (IVAC) were identified based on the 2013 NHSN Surveillance for VAEs (e,g., "See page 92 at https://www.cdc.gov/nhsn/PDFs/pscManual/validation/2013-PSC-Manual-validate.pdf for detailed criteria.")

    duration of mechanical ventilation or discharge from the intensive care unit

Secondary Outcomes (3)

  • Participants With Bacterial Growth

    duration of mechanical ventilation or discharge from the intensive care unit

  • Length of Stay in Intensive Care Unit

    discharge from the intensive care unit

  • Days on Mechanical Ventilation

    discharge from the intensive care unit

Study Arms (2)

Jet Nebulizer Arm

ACTIVE COMPARATOR

The Jet Nebulizer Protocol: * Physician order received for subject, randomization to jet nebulizer occurred. * Jet nebulizer, Misty Max 10™ (Carefusion, CA), placed into spring loaded t-piece between the humidifier and the ventilator (approximately 15 cm from the gas outlet). * Aerosol treatment delivered per physician order at flow rates of 8-10 L/min. * Jet nebulizer to be replaced every 3 days per hospital protocol. a. Prior to every nebulizer change or every 3 days, study staff to be notified in order to obtain cultures.

Device: Jet Nebulizer Arm

Vibrating Mesh Nebulizer Arm

EXPERIMENTAL

* Physician order received for subject, randomization to vibrating mesh nebulizer occurred. * Aeroneb® Solo (Aerogen, Galway, Ireland) vibrating mesh nebulizer to be placed before the heater on the "dry side" of the heater water chamber on the inspiratory ventilator circuit. * Aerosol treatment delivered per physician order. * Mesh nebulizer to be replaced every 30 days per hospital protocol. a. Prior to every nebulizer change or every 3 days, study staff to be notified in order to obtain cultures.

Device: Vibrating Mesh Nebulizer Arm

Interventions

* Physician order received for subject, randomization to vibrating mesh nebulizer occurred. * Aeroneb® Solo (Aerogen, Galway, Ireland) vibrating mesh nebulizer to be placed before the heater on the "dry side" of the heater water chamber on the inspiratory ventilator circuit. * Aerosol treatment delivered per physician order. * Mesh nebulizer to be replaced every 30 days per hospital protocol. a. Prior to every nebulizer change or every 3 days, study staff to be notified in order to obtain cultures.

Also known as: Aeroneb Solo (Aerogen, Galway, Ireland)
Vibrating Mesh Nebulizer Arm

* Physician order received for subject, randomization to jet nebulizer occurred. * Jet nebulizer, Misty Max 10™ (Carefusion, CA), placed into spring loaded t-piece between the humidifier and the ventilator (approximately 15 cm from the gas outlet). * Aerosol treatment delivered per physician order at flow rates of 8-10 L/min. * Jet nebulizer to be replaced every 3 days per hospital protocol. a. Prior to every nebulizer change or every 3 days, study staff to be notified in order to obtain cultures.

Also known as: Misty Max 10 nebulizer (Carefusion, California)
Jet Nebulizer Arm

Eligibility Criteria

Age1 Year+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 1 y/o
  • Intubated with endotracheal tube (ETT) and on mechanical ventilation
  • Patient in all intensive care units at Rush University Medical Center
  • Physician order for aerosolized breathing treatment in medical record

You may not qualify if:

  • Age \< 1 y/o
  • Diaphragmatic paralysis
  • Paraplegic or high spinal cord injury
  • Brain death

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Results Point of Contact

Title
David Vines, PhD, RRT
Organization
Rush University Medical Center

Study Officials

  • Meagan N Dubosky, MS

    Rush University, Respiratory Care Research Coordinator

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2014

First Posted

February 5, 2014

Study Start

September 1, 2013

Primary Completion

October 1, 2014

Study Completion

October 1, 2014

Last Updated

March 21, 2023

Results First Posted

March 21, 2023

Record last verified: 2023-03

Locations